iShares Health Innovation Active ETF
About
iShares Health Innovation Active ETF (US09290C4006) is a US-listed equity ETF tracking the STOXX GLOBAL BREAKTHROUGH HEALTHCARE (Net). With a expense ratio of 0.55%, its costs are on the higher end for an ETF, paying distributions. The fund holds 61 positions across 7 regions with 10M in assets, with heavy concentration — 84% in United States, 95% in Health Care.
Score Breakdown
Scores are scaled 1–10 on a logarithmic curve relative to all ETFs in the database. Last updated: Jun 22, 2026
| Component | Score | Details |
|---|---|---|
| Cost (30%) | 7.5 | Tracking Difference: 10.0 · TD Consistency: — · Expense Ratio: 1.6 |
| Liquidity (25%) | 3.2 | Assets Under Management |
Data sources: provider factsheets, exchange data, and NAV history. Information for educational purposes only — not investment advice.
Ticker BMED
ISIN
Fund Size $10.2M
Issuer iShares
Distribution Pays Distributions
Replication Physical
Inception Sep 2020
Base Currency USD
Index STOXX GLOBAL BREAKTHROUGH HEALTHCARE (Net)
Asset Class Equities
Category Equity Sector
Costs
7.5 This fund has moderate costs compared to similar ETFs.
Expense Ratio0.00%
Expense Ratio0.00%
| Metric | Value |
|---|---|
| Expense Ratio | 0.55% |
Cumulative Returns
Performance across different time periods.
Year to Date+0.00%
1 Year+0.00%
3 Years+0.00%
5 Years+0.00%
Inception+0.00%
Year to Date+0.00%
1 Year+0.00%
3 Years+0.00%
5 Years+0.00%
Inception+0.00%
| Period | Cumulative Return |
|---|---|
| 1 Month | — |
| 3 Months | — |
| 6 Months | — |
| 1 Year | +19.25% |
| 3 Years | +6.86% |
| 5 Years | -0.20% |
| 10 Years | — |
| YTD | -5.12% |
| Since Inception | +2.40% |
Holdings
This fund invests into 61 individual investments.
View all holdings (50)
| # | Holding | Ticker | Weight |
|---|---|---|---|
| 1 | Merck & Co Inc | MRK | 564.42% |
| 2 | Gilead Sciences Inc | GILD | 504.54% |
| 3 | Johnson & Johnson | JNJ | 498.29% |
| 4 | Edwards Lifesciences Corp | EW | 489.63% |
| 5 | BLK CSH FND TREASURY SL AGENCY | XTSLA | 411.10% |
| 6 | Moderna Inc | MRNA | 372.37% |
| 7 | Biogen Inc | BIIB | 372.32% |
| 8 | Thermo Fisher Scientific Inc | TMO | 369.27% |
| 9 | Danaher Corp | DHR | 360.19% |
| 10 | Waters Corp | WAT | 360.09% |
| 11 | Amgen Inc | AMGN | 345.65% |
| 12 | Charles River Laboratories International Inc | CRL | 322.87% |
| 13 | Mettler-Toledo International Inc | MTD | 307.04% |
| 14 | Vertex Pharmaceuticals Inc | VRTX | 305.02% |
| 15 | Dexcom Inc | DXCM | 247.77% |
| 16 | Illumina Inc | ILMN | 245.36% |
| 17 | Bruker Corp | BRKR | 241.83% |
| 18 | Pfizer Inc | PFE | 231.78% |
| 19 | Novartis AG | NOVN | 226.35% |
| 20 | Neurocrine Biosciences Inc | NBIX | 220.47% |
| 21 | Bio-Techne Corp | TECH | 215.79% |
| 22 | Roche Holding AG | ROP | 209.26% |
| 23 | Cytokinetics Inc | CYTK | 200.49% |
| 24 | UnitedHealth Group Inc | UNH | 184.85% |
| 25 | UCB SA | UCB | 164.27% |
| 26 | Axsome Therapeutics Inc | AXSM | 159.13% |
| 27 | Incyte Corp | INCY | 158.15% |
| 28 | AstraZeneca PLC | AZN | 149.82% |
| 29 | AbbVie Inc | ABBV | 147.91% |
| 30 | BioMarin Pharmaceutical Inc | BMRN | 122.05% |
| 31 | REVOLUTION Medicines Inc | RVMD | 115.35% |
| 32 | Bristol-Myers Squibb Co | BMY | 114.64% |
| 33 | Boston Scientific Corp | BSX | 107.95% |
| 34 | ARGENX SE - ADR | ARGX | 105.67% |
| 35 | Wuxi Biologics Cayman Inc | 2269 | 102.01% |
| 36 | Protagonist Therapeutics Inc | PTGX | 86.17% |
| 37 | Alcon AG | ALC | 86.10% |
| 38 | Alkermes PLC | ALKS | 75.39% |
| 39 | Intuitive Surgical Inc | ISRG | 74.46% |
| 40 | Arcus Biosciences Inc | RCUS | 61.06% |
| 41 | Cogent Biosciences Inc | COGT | 55.17% |
| 42 | Dianthus Therapeutics Inc | DNTH | 52.56% |
| 43 | Apogee Therapeutics Inc | APGE | 50.96% |
| 44 | Insmed Inc | INSM | 46.23% |
| 45 | Biontech Se | BNTX | 45.11% |
| 46 | USD CASH | USD | 39.64% |
| 47 | Erasca Inc | ERAS | 16.74% |
| 48 | Ultragenyx Pharmaceutical Inc | RARE | 12.35% |
| 49 | EIKON THERAPEUTICS INC | EIKN | 11.79% |
| 50 | AVALO THERAPEUTICS INC | AVTX | 11.24% |
Sectors
Allocation by industry sector.
| Sector | Weight |
|---|---|
| Health Care | 9514.00% |
| Unknown | 486.00% |
Regions
Geographic allocation by country of risk.
| Country | Weight |
|---|---|
| United States | 8425.00% |
| Switzerland | 522.00% |
| UNKNOWN | 486.00% |
| Belgium | 164.00% |
| United Kingdom | 150.00% |
| Netherlands | 106.00% |
| Hong Kong SAR China | 102.00% |
| Germany | 45.00% |
Similar ETFs
Other funds tracking Equity Sector indices.
iShares U.S. Technology ETF
IYW·Expense Ratio 0.38%
iShares Expanded Tech-Software Sector ETF
IGV·Expense Ratio 0.39%
iShares Expanded Tech Sector ETF
IGM·Expense Ratio 0.39%
iShares Global Tech ETF
IXN·Expense Ratio 0.39%
iShares Global REIT ETF
REET·Expense Ratio 0.14%
iShares U.S. Real Estate ETF
IYR·Expense Ratio 0.38%
Feedback
ETFs
Basket
Compare